Evoke Wealth’s OptiNose OPTN Stock Holding History

Evoke Wealth’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-36	Closed	-$5.02K	–	1291
2019 Q4	$5.02K	Hold	36	–	–	﹤0.01%	910
2019 Q3	$3.81K	Buy	+36	New	+$3.59K	﹤0.01%	1069

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Evoke Wealth's OPTN Position: Q1 2020 in Review

Evoke Wealth sold out of OptiNose (OPTN) in Q1 2020, closing a stake of 36 shares — an estimated $5.02K sold.

Evoke Wealth first reported a position in OPTN in Q3 2019 and held it in 2 quarters. The position peaked at $5.02K in Q4 2019. 81 funds tracked by Wall St. Rank hold OPTN as of Q1 2020.

Evoke Wealth reported no remaining OptiNose position as of Q1 2020 after selling out during the quarter.
Evoke Wealth sold 36 OptiNose shares in Q1 2020, an estimated $5.02K.
Evoke Wealth first reported a position in OptiNose in Q3 2019 and held it in 2 quarters.
Evoke Wealth's OptiNose position peaked at $5.02K in Q4 2019.
81 funds tracked by Wall St. Rank held OptiNose as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.